Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Bailong Chuangyuan Bio-tech Co., Ltd. is a leading biotechnology company specializing in the research, development, and industrial production of functional sugar alcohols, prebiotics, and dietary fibers. The company's core product portfolio includes resistant dextrin, isomalto-oligosaccharide, xylo-oligosaccharide, polydextrose, and allulose, which serve as health-oriented alternatives to traditional sweeteners. Utilizing advanced enzymatic engineering and large-scale fermentation technologies, the company provides ingredients aimed at improving digestive health and managing metabolic conditions like diabetes and obesity. Shandong Bailong Chuangyuan is a publicly traded entity on the Shanghai Stock Exchange and operates as a major global supplier for the food, beverage, and pharmaceutical industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Bailong Chuangyuan.